A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.
Scientists have discovered that psychological stress can induce immune responses to food that can cause symptoms when that food is eaten again, findings that demonstrate the potential role of psychological stress in food-induced symptoms of irritable bowel syndrome (IBS), according to a recent study published in Gastroenterology.
Investigators in the laboratory of Gemma Carvill, PhD, have discovered novel molecular underpinnings of Dravet syndrome, a rare genetic form of epilepsy in children, that may serve as promising therapeutic targets, according to a recent study.
Northwestern Medicine scientists have uncovered new insights into how neurofilaments act like Velcro in neurodegenerative diseases, clogging up the brain and preventing normal function, according to a study published in the journal JCI Insight.
A new Northwestern Medicine study suggests a promising alternative to current approaches to Alzheimer’s disease: enhancing the brain’s own immune cells to clear amyloid plaques more effectively.
Northwestern Medicine investigators have uncovered new insights into how metabolic dysfunction contributes to Parkinson’s disease, according to a study published in Nature Communications.
Scientists have discovered a unique proteomic signature expressed in the blood of persons living with HIV (human immunodeficiency virus) that is associated with age and higher risk for heart failure, findings that can help identify new therapeutic targets for heart failure among both people living with and without HIV.
Vaccination status does not impact the severity of neurological symptoms of long COVID, according to a Northwestern Medicine-led study published in Brain Communications.
A new Northwestern Medicine study using a novel medication-based approach successfully reversed existing inguinal hernias in male mice and fully restored their normal anatomy without surgery.
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.
Notifications